🌎 Posts shared on Facebook and Twitter claim monkeypox is 'only circulating in countries distributing the Pfizer-BioNTech vaccine'. This is false ❌ There is no link between monkeypox and the vaccine, experts say
But medical experts told AFP the claim that monkeypox outbreaks are linked to Pfizer-BioNTech's Covid vaccine is false., although monkeypox is not highly contagious, it can be"transmitted from one person to another by close contact with lesions, body fluids, respiratory droplets and contaminated materials such as bedding."
Peter Collignon, a professor from the Australian National University Medical School, told AFP that monkeypox existed for decades before Covid-19 vaccines were created. The claim that the WHO has not received reports of monkeypox cases from countries not using the Pfizer-BioNTech vaccine is also false.-- have reported at least one case of monkeypox as of August 9 but their respective health authorities do not administer Pfizer-BioNTech's vaccine to the public.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsPfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect against the newer BA.4 and BA.5 sub-variants of the coronavirus later this month.
Weiterlesen »
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsPfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect against the newer BA.4 and BA.5 sub-variants of the coronavirus later this month.
Weiterlesen »
Pfizer just started a late-stage clinical trial of a Lyme disease vaccineIf the trial succeeds, the vaccine could be the first human immunization for Lyme disease in the U.S. in two decades.
Weiterlesen »
Pfizer to buy South SF-based Global Blood Therapeutics in $5.4B dealPfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic.
Weiterlesen »
Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln dealPfizer Inc on Monday agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics , as it looks to capitalize on a surge in revenue from its COVID-19 vaccine and treatment.
Weiterlesen »
Pfizer Agrees to $5.4 Billion Deal for Global Blood TherapeuticsPfizer has agreed to buy Global Blood Therapeutics for $5.4 billion, a deal that will give the big drugmaker a foothold in the treatment of sickle-cell disease.
Weiterlesen »